Statistics for Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer genomics consortium (CGC) working group for myelodysplastic syndrome, myelodysplastic/myeloproliferative and myeloproliferative neoplasms

Total visits

views
Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer genomics consortium (CGC) working group for myelodysplastic syndrome, myelodysplastic/myeloproliferative and myeloproliferative neoplasms 337

Total visits per month

views
November 2023 5
December 2023 10
January 2024 4
February 2024 8
March 2024 11
April 2024 5
May 2024 0

File Visits

views
Kanagal-Shamanna_2018_assessing.pdf 1002

Top country views

views
United States 211
China 27
Germany 25
Australia 10
United Kingdom 10
Ukraine 7
Canada 4
Spain 4
Russia 4
Malaysia 3
Portugal 2
France 1

Top city views

views
Wilmington 53
Fairfield 29
Cambridge 20
Ann Arbor 16
Houston 16
Kiez 16
Gunzenhausen 7
Jacksonville 7
Kiev 7
Brisbane 6
Shanghai 6
Charlotte 3
Chicago 3
Seattle 3
Toronto 3
Warrington 3
Brooklyn 2
Cleveland 2
Indianapolis 2
Kuala Lumpur 2
Newcastle 2
Omaha 2
Sintra 2
Valencia 2
White Plains 2
Alaquàs 1
Alexandria 1
Atlanta 1
Baltimore 1
Bloomsbury 1
Bonnybridge 1
Endingen 1
Glasgow 1
Kansas City 1
Kurgan 1
Leeds 1
Merton 1
Monmouth Junction 1
Montreal 1
Moscow 1
Mount Laurel 1
Mt. Pleasant 1
New York 1
Northampton 1
Norton Summit 1
Nürnberg 1
Paris 1
Philadelphia 1
Portland 1
Redmond 1
Rochester 1
Saint Louis 1
Saint Petersburg 1
Salamanca 1
San Francisco 1
Scottsdale 1
Seremban 1
Shenzhen 1
Sydney 1
Wuhan 1
Zhengzhou 1
Zhoushan 1